Computational Drug Discovery Services

Overview

Computational drug discovery has become an essential approach for researchers, scientists, and pharmaceutical industries working to combat complex and life-threatening diseases. By integrating advanced computational methods, this approach accelerates and streamlines the drug discovery and development pipeline while significantly reducing costs and time. With the rapid expansion of biological data—including macromolecular structures and small molecule libraries—computational drug discovery is now applied across nearly every stage of the development process.

Role of Bioinformatics in Drug Discovery

Bioinformatics plays a critical role in enhancing drug discovery by enabling rapid identification of therapeutic targets and efficient screening and optimization of candidate compounds. It also supports the prediction of potential side effects and drug resistance mechanisms, improving the safety and efficacy of new therapeutics. The integration of high-throughput datasets—such as genomics, epigenomics, transcriptomics, proteomics, and ribosome profiling—has significantly advanced mechanism-based drug discovery and drug repurposing strategies.

Our Services Include

• Target Identification & Validation: Identification of novel therapeutic targets using genomic and proteomic data.
• Ligand Selection & Preparation: Curating and preparing compound libraries for screening.
• Virtual Screening (HTVS): High-throughput virtual screening of large compound databases.
• Molecular Docking: Binding affinity prediction and pose analysis.
• Pharmacophore Modeling: Identification of essential structural features for activity.
• ADMET Prediction: Absorption, distribution, metabolism, excretion, and toxicity profiling.
• Drug Repurposing: Identifying new uses for existing drugs.